Condition: Chronic CML or Ph+ Leukemia Intervention: Drug – Dasatinib (Sprycel)

Principal Investigator:
Kirov, Ivan

Research Coordinator:
Laura Gates
(714) 509-8646


  • Clinical Trial Info
  • IRB Number: 90325
  • Sponsor: Bristol-Myers Squibb
  • Research Type: Adolescents and Young Adults, Leukemia/Lymphoma,Recurrent/Refractory Cancer
  • Phase: II
  • Status: Active - Closed to Enrollment